We investigated the estrogenic activity of commercial insecticides fenamiphos, fenthion, methiocarb, propaphos, sulprophos, and temephos as well as some phenolic compounds obtained as a result of their degradation. Using a yeast two-hybrid assay, the relative activities of 4-(methylthio)phenol, 3-methyl-4-(methylthio)phenol, 3,5-dimethyl-4-(methylthio)phenol, and 4,4 -thiodiphenol (TDP) were evaluated as 11, 10, 4, and 1000% (10 times) that of bisphenol-A. To reveal the binding abilities of the abovementioned phenolic compounds with respect to human estrogen receptor α (hERα), we carried out ER-ELISA and found that all compounds had significant abilities, particularly, TDP. From the viewpoint of bioisosterism, we discussed the similarity between a vinylene-group, -CH=CH-, and a thioether-group, -S-. We suggest that an alkylthio-group substituted at the "para"-position of a phenol ring plays a key role in the binding abilities of the investigated phenolic compounds.
INTRODUCTION
Organophosphorus and carbamate insecticides (OP-CMIs) are generally used for pest control in agriculture, such as in the cultivation of rice and/or fruits. Given their low cost, broad-spectrum effectiveness, and multi-pest control capability, they have been also utilized in non-agricultural applications including pet-insect, mosquito, and gnat controls. 1, 2) However, at the same time, it has been pointed out that a portion of crops, and some environmental media such as surface water or soils, are contaminated with OP-CMIs. [3] [4] [5] In addition, it has been suggested that these may affect human health or ecological systems as a result of unintentional bioactivity. [6] [7] [8] [9] OP-CMIs exhibit inhibition of the enzyme cholinesterase, and mainly transform or degrade into two kinds of molecules known as oxonand phenolic-compounds. [10] [11] [12] The former, derived from oxidation processes such as biological * To whom correspondence should be addressed: Graduate School of Nutritional and Environmental Sciences, University of Shizuoka, 52-1 Yada, Suruga, Shizuoka 422-8526, Japan. Tel. & Fax: +81-54-264-5785; E-mail: makinom@u-shizuokaken.ac.jp metabolism, exhibit a more marked ability to inhibit cholinesterase than do OP-CMIs themselves. The latter, induced from further metabolism or degradation through photo-irradiation, for example, show only a weak ability to inhibit cholinesterase. Therefore, in terms of inhibiting the enzyme cholinesterase, the phenolic-compounds have been regarded as a more secure product than OP-CMIs and their oxon-compounds. In agricultural chemistry, in order to maintain the inhibition (or in other words, to decrease the rate of degradation), one or more sulfur atoms have been inserted into the molecular skeleton of OP-CMIs. This is because sulfur atoms tend to be oxidized to sulfoxide and then to sulfone moieties, an outcome that is preferable to that of degradation under oxidative conditions. 13, 14) In the 1990s, it was pointed out that a portion of certain synthetic chemicals can disrupt the sensitive endocrine systems of humans or other vertebrates by mimicking or inhibiting endogenous hormones such as estrogens and/or androgens. 15) These chemicals are called endocrine disrupting chemicals (EDCs), and it has been suspected that various commercial insecticides may be EDCs, given that they are popular and ubiquitous. Thus, many in vitro and in vivo bioassays have been carried out for insecticides including OP-CMIs. [16] [17] [18] [19] While it has been determined that OP-CMIs do not cause serious and urgent effects on human health or ecological systems, it has also been pointed out that their environmental persistence and/or fate should be continuously investigated from the perspective of total risk and life cycle assessment. [20] [21] [22] [23] Furthermore, it was found that the estrogenic potency of some phenolic-compounds, in particular, bisphenol-A (BPA), should be investigated closely since many (but not all) of them possess a common feature, displaying substantial estrogen binding activity from structure-activity relationships (SAR). 17) From SAR analysis, Nishihara et al. deduced that most estrogenic compounds have a phenol ring with a moiety of appropriate hydrophobicity at its "para"-position. 17) Here, it should be noted that the estrogenic potency of alkyl(thio)phenols such as a methyl(thio)phenol has not yet been evaluated in detail. In addition, not only can the alkylthio moiety be regarded as a kind of hydrophobic one, but the phenolic-compounds substituted with the moiety at their "para"-position are also the main degradation products for commercial insecticides known as fenamiphos, fenthion, methiocarb, propaphos, sulprophos, and temephos. [24] [25] [26] [27] [28] [29] In the present study, we aimed to evaluate the estrogenic potency of three alkyl(thio)phenols and 4,4 -thiodiphenol (TDP) by using the yeast twohybrid assay incorporating the human estrogen receptor α (hERα) and hERα competitive enzymelinked immunosorbent assay (ER-ELISA). In addition, we compared their potency with that of the insecticides themselves. Furthermore, the estimated binding ability to hERα was discussed on the basis of bioisosteric replacement between a vinylenegroup, -CH=CH-, and a thioether-group, -S-, in the compounds.
MATERIALS AND METHODS
Chemicals --3-methyl-4-(methylthio)phenol (MMP, > 95.0% purity), 4-(methylthio)phenol (MTP, > 98.0% purity), and TDP (> 98.0% purity) were purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Fenamiphos (92.5% purity), fenthion (98.0% purity), methiocarb (98.5% purity), sulprofos (90.0% purity), temephos (96.0% purity) were purchased from Dr. Ehrenstorfer GmbH (Augsburg, Germany). Propaphos (> 97.0% purity) were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). These chemicals were used for measurement without further purification. All other reagents used were of the purest grade and commercially available. Figure 1 shows the test compounds including 3,5-dimethyl-4-(methylthio)phenol (DMP, Fig. 1I ; see bellows). Hereafter, we refer to the compounds illustrated in Fig. 1G-1J as pS-alkyl phenols. Synthesis and Characterization --DMP was synthesized by sulfenylation of 3,5-dimethylphenol using dimethyl disulfide under acidic conditions. 30) A mixture of 3,5-dimethylphenol (6.1 g, 50 mmol) and sulfuric acid (0.2 g) was heated to 170 • C and then cooled 155 • C. Dimethyl disulfide (4.7 g, 50 mmol) was added over a period of 30 min, and the mixture was heated at 155 • C for 5 hr. The charcoal brown product was then fractionally distilled under aspirator pressure; fractions between 127 and 144 • C, which were collected and combined, yielded 0.28 g. To obtain pure DMP, the fraction was purified with HPLC (Shimadzu LC-20AD HPLC system; Shimadzu Corporation, Kyoto, Japan). HPLC purification was performed on a reverse-phase column with endcapping (C18; particle size, 5 µM; pore size, 100 Å; column length, 250 mm; i.d., 20 mm; Inertsil ODS-3; GL Sciences, Inc., Tokyo, Japan) employing the same C18 packing guard column (column length, 50 mm; i.d., 20 mm; GL Sciences, Inc.). The mobile phase comprised acetonitrile/water (70/30, v/v) in an isocratic mode for 45 min, and the solvent flow rate was 8 ml/min. The fractions containing DMP were collected (the elution time was 15-17 min), and the solvent was evaporated to yield a brown liquid (0.034 g) whose purity was 98% (GC). The product was characterized by nuclear magnetic resonance (NMR) spectroscopy (ECA-500 spectrometer, JEOL Ltd., Tokyo, Japan) and high-resolution (HR) fast atom bombardment (FAB)/MS (FAB + MS; JMS-700 instrument, JEOL Ltd.). NMR spectra were observed in chloroform-d solution, and all of the chemical shifts were obtained in parts per million downfield from tetramethylsilane (TMS). Details of NMR spectra and FAB/MS data were as follows. 1 Yeast Two-hybrid Assay for hERα --The estrogenic activities of the test compounds were examined with the yeast two-hybrid estrogenicity assay system developed by Nishikawa et al. and modified using yeast cells (Saccharomyces cervisiae Y190); hERα and coactivator TIF2 had been introduced into this system. 31) The expression plasmids for the hormone receptor ligand binding domain and pGAAD424-TIF-2 were introduced into the yeast cells that carried the β-galactosidase reporter gene. The assay was adapted to a chemiluminescent reporter gene (for β-galactosidase) method by employing a 96-well culture plate. 32) To measure the estrogenic activity in this system, aliquots from test chemical solutions were incubated for 4 hr at 30 • C, where yeast cells were preincubated overnight at 30 • C in a modified synthetic dextrose medium (not containing tryptophan and leucine). After the incubation period, a mixed solution of 2 mg/ml of zymolyase (Zymolyase 20T; Seikagaku, Tokyo, Japan) and a commercial reporter gene assay kit (Aurora Gal-XE; ICN Pharmaceuticals, Costa Mesa, CA, U.S.A.), which induces chemiluminescence and enzymatic digestion, was added at a 5 : 3 ratio. This was followed by the addition of a light-emission accelerator reagent. The intensity of the chemiluminescence produced by the released β-galactosidase was measured using a 96-well plate luminometer (Labsystems Luminoskan, Type 391A, Labsystems, Helsinki, Finland). The details of the assay have been published elsewhere. 33) The estrogenic activity was recorded as the effective concentration (EC) × 10, which is defined as the concentration of the test solution required to produce a chemiluminescent signal 10 times stronger than that of the blank control. The relative activity (RA) was calculated on the basis of the follows equation: RA (%) = (EC × 10 for BPA)/(EC × 10 for test compounds) × 100. In the present study, BPA (analytical grade) in Fig. 1K and E 2 (> 97.0% purity) in Fig. 1L were used as the reference compound and the positive control, respectively. The working range was set between 31.3-2000 pM for E 2 , 313-20000 nM for BPA, 31.3-2000 nM for TDP, and 3125-200000 nM for MTP, MMP, DMP, and all other insecticides. These assays were repeated in triplicate for all of the tested compounds. ER-ELISA --The hERα competitive binding assay was conducted using an Estrogen-R (α) Competitor Screening kit (Wako Pure Chemical Industries, Ltd.), in accordance with the manufacturer's protocol. In brief, a mixture of fluorescent-labeled E 2 and the test compounds were added to the wells of a plate coated with hERα, and they were allowed to compete at room temperature for 2 hr. Af-ter washing the wells with the wash-solution in the kit, the assay solution was added to each well. The fluorescence intensity in each well was read with a microplate reader (Wallac 1420 ARVOsx, Perkin-Elmer Inc., MA, U.S.A.) at an excitation and emission wavelengths of 485 and 535 nm, respectively. The inhibition curves for fluorescentlabeled E 2 binding were obtained on the basis of a reduction in the fluorescence intensity. IC 50 values, i.e., the concentrations at which replacement of fluorescent-labeled E 2 was 50%, were calculated using the inhibition curves. The relative binding ability (RBA) was calculated as follows: RBA (%) = (IC 50 for BPA)/(IC 50 for test compounds) × 100. In the present study, BPA (analytical grade) and E 2 (> 97.0% purity) were used as the reference compound and the positive control, respectively. The working range of the assay was set at 1.56-50 nM for E 2 , 625-20000 nM for BPA, 1250-40000 nM for TDP, 12500-400000 nM for DMP, and 50000-1600000 nM for MTP and MMP. These assays were also repeated in triplicate for all of the tested compounds. Calculations --We calculated molecular volumes by using GaussView ver. 2.1 and Gaussian R 98W ver. 5.4. 34) The structure of a molecule was optimized in terms of a semi-empirical method with the AM1 Hamiltonian. Its volume, in an appropriate solvent replaced by a polarized continuum (PCM model), was then calculated on the basis of the B3LYP method with the 3-21G basis set. 35) All calculations were performed using a DELL Dimension 8300 micro-computer.
RESULTS AND DISCUSSION

Estrogenic Activity of Tested Compounds
First, the estrogenic potency of the pS-alkyl phenols, TDP and the commercial insecticides illustrated in Fig. 1 were evaluated with the yeast twohybrid assay. Figure 2 shows the observed doseresponse curves and Table 1 indicates the values for EC × 10 and RA% estimated from the curves. It was found that the activity of TDP was 10 times that of BPA, which is regarded as a significant EDC in many countries. In addition, RA% values for MTP, MMP, and DMP were estimated to be 11, 10, and 4%, respectively, of BPA activity. Although these values were smaller than that of BPA, it appeared that the compounds tested were weakly active. In addition, the EC × 10 of E 2 was estimated 0.3 ± 0.07 nM (the dose-response curve was not shown). On the other hand, dose-response relationships were not observed for all of the commercial insecticides in the range of the tested concentrations (their curves are not shown in the Fig. 2 ). As described above, these pS-alkyl phenols and TDP, which are the main degradation-products of commercial insecticides, have been regarded as safe compounds in terms of their cholinesterase-inhibiting activity. However, in terms of estrogenic activity, it should be noted that they exhibit more significant activity than insecticides themselves.
hERα Binding Ability of Tested Compounds
Next, we carried out ER-ELISA to evaluate the binding ability of pS-alkyl phenols and TDP to hERα. From the dose-response curves shown in Fig. 3 , the RBA% of pS-alkyl phenols and TDP were estimated to be in a range between 2-141% (Table 1) . Regarding RBA% and RA% values, the former was smaller than the latter; for example, although the RA% of TDP was about 10 times that 
Compounds
Estrogenic activity hERα binding ability
MTP 152000 ± 45000 11 1040000 ± 45000 2 MMP 159000 ± 54000 10 726000 ± 49000 2 DMP 449000 ± 103000 4 271000 ± 14000 6 TDP 1600 ± 150 1000 12000 ± 1200 141 BPA 17000 ± 600 100 17000 ± 700 100 a) Values are presented as the mean ± standard deviation of triplicate. b) EC = effective concentration; EC × 10 = the concentration of test compounds showing 10% of the activity of blank controls. c) RA = relative activity (BPA = 100). d) IC 50 = 50% inhibition concentration. e) RBA = relative binding ability (BPA = 100).
of BPA (a reference compound), its RBA% was estimated to be 1.5 times of that observed with ER-ELISA. A similar lowering of the RBA% was also observed for MTP, MMP, and DMP. However, it was also found that the ordering of activities obtained from both bioassays indicated the same trend: TDP > BPA > MTP, MMP, and DMP. Therefore, we determined that pS-alkyl phenols and TDP possess binding ability to hERα, and that the estrogenic activity observed from the yeast two-hybrid assay is responsible for this ability. In addition, the IC 50 of E 2 was estimated 25 ± 1 nM (the dose-response curve was not shown).
An Explanation of Binding Ability on the Basis of Bioisosterism
When considering the chemical structure and estrogenic activity, it has previously been pointed out by Nishihara et al. that most of the positive compounds observed on the basis of the yeast twohybrid assay possess a phenol ring with a moiety of appropriate hydrophobicity at the "para"-position. 17) In medicinal chemistry, a term known as "bioisosterism," which describes functional groups related in structure and possessing similar biological effects, has been introduced. 36) Friedman defined the terms, and Burger subsequently expanded the definition as follows: "Bioisosteres are compounds or groups that possess nearly equal molecular shapes and volumes, approximately the same distribution of electrons, and which exhibit similar physical properties such as hydrophobicity. Bioisosteric compounds affect the same biochemically associated systems as agonist or antagonists and thereby produce biological properties that are related to each other." 37, 38) Benzene and thiophene have been cited as typical examples of bioisosteric compounds. There are also many reports based on practical uses of bioisosteric replacement of one (or reported that a thiophene ring is cross-superimposed with a phenyl ring by using an Autodock program package, as shown in Fig. 4A . 39) In addition, as shown in Fig. 4B , Ghalit et al. reported that the conformational constraint of a thioether-part, -S-, is a similar to that of alkene or alkane. 40) In the present study, the pS-alkyl phenols and TDP can be regarded as positive compounds in terms of the estrogenic activity from the findings based on two bioassays. As a plausible reason for this positive activity, it should be noted that bioisosteric replacement between TDP and 4,4 -dihydroxystilbene (DHS) is valid, as shown in Fig. 4C . It is well known that DHS possesses estrogenic binding ability, and its potency has been estimated on the basis of an ER binding assay. 41) Table 2 shows their molecular volumes and RBA% to hERα together with those of 4,4 -methylenediphenol (MDP) and 4,4 -ethylenediphenol (EDP). 41, 42) As regards MDP 42) and EDP, although their molecular volumes are similar to that of TDP, they possess a methylene-group (-CH 2 -) or an ethylene-group (-CH 2 -CH 2 -), both of which have quite different electron-distributions than a thioether-group (-S-) or a vinylene-group (-CH=CH-) in terms of the presence or absence of n-or π-electrons at the moieties. Judging from not only from the electron distributions of the moiety but also from the molecular volumes (Table 2 ), it appears that the biochemical characteristics of TDP are similar to that of DHS.
In terms of cholinesterase inhibition, pS-alkyl phenols and TDP have been regarded as more secure compounds than OP-CMIs or their oxoncompounds. However, an assessment of the total risk and life cycles of OP-CMIs illuminates how greater attention should be given to environmental concentrations of pS-alkyl phenols and TDP as well. This is underscored by the results of the present study, which found that the pS-alkyl phenols and TDP tested possess unintentional bioactivities such as estrogenic activity.
